Deputy Director, Liaison to the EMA, Office of International Programs, OC, FDA
Sandra L. Kweder, MD, is Deputy Director of the Europe Office in the FDA Office of International Programs. Dr. Kweder previously served for more than a decade as Deputy Director, Office of New Drugs, in FDA’s Center for Drug Evaluation & Research, where she actively led numerous...
Read More →
Scientific officer, PRIME Coordinator, Scientific and Regulatory Management Dept, European Medicines Agency (EMA)
Zahra Hanaizi joined EMA in 2007 as Product Team Leader, managing centralised medicinal products initial marketing authorisation applications, maintenance and life-cycle activities, mostly in the therapeutic area of Oncology. Since 2015, she has been working on the creation, implementation...
Read More →CJ
Associate Director for Review Management, CBER, FDA
*
Senior Director Regulatory Affairs, Alnylam Pharmaceuticals
Samuel Rigourd joined Alnylam Pharmaceuticals in 2016 as Senior Director of Regulatory Affairs, where he leads the global registration strategy of a new class of medicines, RNA interference therapeutics. He has over 15 years of experience in regulatory affairs, in various roles both...
Read More →
International Policy Analyst, Office of Global Policy and Strategy, European Off, FDA
Lieutenant Commander Shannon Thor is a pharmacist and officer in the United States Public Health Service, serving as an international policy analyst in FDA's Europe Office. LCDR Thor’s FDA career began when she joined the Office of Health and Constituent Affairs in 2014, serving...
Read More →
